Oracle is behind the AI demand curve, but this could spell accelerating growth and significant upside for investors.

Oracle's revenue and earnings growth have both been accelerating, driven by RPO backlogs. Click here to read more about ORCL ...

Oracle's earnings numbers in the third quarter were impressive, and the company boosted its guidance for next year.

Shares of Oracle and chipmakers rose on Wednesday after a strong earnings report signaled AI demand remains healthy, but ...

Oracle bought 15% of TikTok's U.S. operations in January after China's ByteDance was forced by U.S. law to divest.

Discover how Oracle's earnings report could influence its full-year 2026 guidance and long-term growth strategy. Read more here.

Ader reiterated an Overweight rating on Oracle shares with a price target of $300. Some analysts adjusted their outlooks ...

Oracle Corp. (NYSE:ORCL) reports strong Q3 results, with revenue of $17.19B and adjusted EPS of $1.79. Q4 revenue expected to grow 18-20%.

Oracle (ORCL) closed at $141.31 in the latest trading session, marking a -4.57% move from the prior day. The stock's performance was behind the S&P 500's daily loss of 1.04%. Meanwhile, the Dow lost 1 ...

Oracle is making its Health Clinical AI Agent available to NHS trust and private practices. The note-taking software has been piloted at a number of hospital trusts in the UK, including Barts Health ...

LONDON, Feb. 12, 2026 /PRNewswire/ -- Following a successful pilot program at several NHS Trusts, Oracle Health today announced its Clinical AI Agent, Clinical Note is now available in the UK. The new ...